We’re excited to announce the BD and Decode Health strategic partnership that will accelerate innovation and advance precision medicine. Together, we’re working to advance at home collections for molecular biomarkers like RNA using a simple finger stick. Our work could unlock groundbreaking innovations for biomarker discovery and routine screening across multiple disciplines from oncology to autoimmune diseases and beyond. At-home testing can significantly improve efficiency and enhance diversity in clinical trials, speeding the development of potentially life-saving treatments.
Decode Health was recently honored for its commitment to advancing precision medicine and extraordinary promise for future endeavors with a 2022 Nashville Entrepreneur Center NEXT Award for healthcare innovation.
NIH Awards Decode Health $248K Grant to Detect and Distinguish Progressive Forms of Multiple SclerosisDecodeHealth2022-11-09T14:59:23-06:00
Decode Health today announced it received a $248,000 one year grant from the National Institutes of Health (NIH) to create new methods to distinguish relapsing-remitting and progressive forms of multiple sclerosis (MS).
Decode Health Collaborates with Quest Diagnostics to Speed Biomarker Discovery for Drug and Diagnostics DevelopmentDecodeHealth2022-10-18T08:35:06-06:00
Decode Health, a healthcare AI company that enables a partner ecosystem to innovate and solve data challenges involving disease risk, today announced a new phase of its collaboration with Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, to empower drug and diagnostics research and development in the growing fields of metabolic disease and autoimmune neurology.
Decode Health, a rapidly growing healthcare AI company that enables a partner ecosystem to innovate and solve data challenges involving disease risk, announced today that two healthcare industry veterans will expand their current advisory roles within the company.
Decode Health was recently recognized with an AI Innovator Award at the DataRobot AIX 22 global virtual conference. DataRobot is a Boston-based AI cloud platform company that works with customers worldwide across industries and verticals, including almost 40% of Fortune 50 companies.
The teams at Decode Health and IQuity Labs have collaborated for several years leveraging AI to deliver on the power of genomic data. Today, the companies announced they will now operate as Decode Health.
As featured on tennesseelookout.com Decode Health had been subleasing office space in Cummins Station in Nashville when Covid-19 forced the team home in March. The company, which provides predictive disease insights to national laboratories, moved [read more...]
New members bring cross-industry insights to the company Nashville, Tenn. – Nov. 11, 2020 – Chase Spurlock, PhD, founder and CEO of Decode Health, announced the addition of two members to the company's Strategic Advisory Board. [read more...]
One-year-old technology startup Decode Health has developed a predictive artificial intelligence platform that identifies emerging trends in the COVID-19 outbreak, providing governments and other organizations early insights to where resources need to be allocated to provide targeted outreach among high-risk populations.